全文获取类型
收费全文 | 12593篇 |
免费 | 1101篇 |
国内免费 | 407篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 31篇 |
妇产科学 | 40篇 |
基础医学 | 866篇 |
口腔科学 | 36篇 |
临床医学 | 891篇 |
内科学 | 473篇 |
皮肤病学 | 33篇 |
神经病学 | 576篇 |
特种医学 | 207篇 |
外科学 | 316篇 |
综合类 | 2929篇 |
现状与发展 | 3篇 |
预防医学 | 290篇 |
眼科学 | 1740篇 |
药学 | 538篇 |
19篇 | |
中国医学 | 4988篇 |
肿瘤学 | 68篇 |
出版年
2024年 | 55篇 |
2023年 | 167篇 |
2022年 | 486篇 |
2021年 | 718篇 |
2020年 | 599篇 |
2019年 | 458篇 |
2018年 | 415篇 |
2017年 | 525篇 |
2016年 | 507篇 |
2015年 | 488篇 |
2014年 | 1159篇 |
2013年 | 773篇 |
2012年 | 905篇 |
2011年 | 983篇 |
2010年 | 831篇 |
2009年 | 629篇 |
2008年 | 463篇 |
2007年 | 526篇 |
2006年 | 445篇 |
2005年 | 439篇 |
2004年 | 277篇 |
2003年 | 283篇 |
2002年 | 243篇 |
2001年 | 218篇 |
2000年 | 221篇 |
1999年 | 147篇 |
1998年 | 110篇 |
1997年 | 90篇 |
1996年 | 74篇 |
1995年 | 87篇 |
1994年 | 79篇 |
1993年 | 58篇 |
1992年 | 49篇 |
1991年 | 61篇 |
1990年 | 28篇 |
1989年 | 46篇 |
1988年 | 33篇 |
1987年 | 30篇 |
1986年 | 34篇 |
1985年 | 51篇 |
1984年 | 38篇 |
1983年 | 24篇 |
1982年 | 35篇 |
1981年 | 35篇 |
1980年 | 18篇 |
1979年 | 76篇 |
1978年 | 13篇 |
1977年 | 13篇 |
1976年 | 14篇 |
1975年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Jae Yun Ahn Jung Bae Park Sungbae Moon Jae Wan Cho Dong Ho Park 《Ophthalmic epidemiology》2020,27(2):105-114
ABSTRACT
Purpose
Work-related eye injuries have been reported with a variety of epidemiologic and clinical characteristics. We aimed to identify epidemiologic characteristics of work-related eye injuries and risk factors associated with severe injury in a large metropolitan city. 相似文献2.
3.
Edward J. Holland Walter O. Whitley Kenneth Sall Stephen S. Lane Aparna Raychaudhuri Steven Y. Zhang 《Current medical research and opinion》2016,32(10):1759-1765
Objective: Report efficacy findings from three clinical trials (one phase 2 and two phase 3 [OPUS-1, OPUS-2]) of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease (DED).Research design and methods: Three 84-day, randomized, double-masked, placebo-controlled trials. Adults (≥18 years) with DED were randomized (1:1) to lifitegrast 5.0% or matching placebo. Changes from baseline to day 84 in signs and symptoms of DED were analyzed.Main outcome measures: Phase 2, pre-specified endpoint: inferior corneal staining score (ICSS; 0–4); OPUS-1, coprimary endpoints: ICSS and visual-related function subscale (0–4 scale); OPUS-2, coprimary endpoints: ICSS and eye dryness score (EDS, VAS; 0–100).Results: Fifty-eight participants were randomized to lifitegrast 5.0% and 58 to placebo in the phase 2 trial; 293 to lifitegrast and 295 to placebo in OPUS-1; 358 to lifitegrast and 360 to placebo in OPUS-2. In participants with mild-to-moderate baseline DED symptomatology, lifitegrast improved ICSS versus placebo in the phase 2 study (treatment effect, 0.35; 95% CI, 0.05–0.65; p?=?0.0209) and OPUS-1 (effect, 0.24; 95% CI, 0.10–0.38; p?=?0.0007). Among more symptomatic participants (baseline EDS ≥40, recent artificial tear use), lifitegrast improved EDS versus placebo in a post hoc analysis of OPUS-1 (effect, 13.34; 95% CI, 2.35–24.33; nominal p?=?0.0178) and in OPUS-2 (effect, 12.61; 95% CI, 8.51–16.70; p?<?0.0001).Limitations: Trials were conducted over 12 weeks; efficacy beyond this period was not assessed.Conclusions: Across three trials, lifitegrast improved ICSS in participants with mild-to-moderate baseline symptomatology in two studies, and EDS in participants with moderate-to-severe baseline symptomatology in two studies. Based on the overall findings from these trials, lifitegrast shows promise as a new treatment option for signs and symptoms of DED. 相似文献
4.
5.
《European annals of otorhinolaryngology, head and neck diseases》2022,139(2):65-71
ObjectivesTinnitus can induce disabling psychological suffering, requiring an integrative multimodal approach, combining neuromodulation and psychotherapeutic methods. We sought to evaluate the therapeutic efficacy and acceptability of Eye Movement Desensitization and Reprocessing (EMDR) in tinnitus.Materials and methodsThis was a single-center prospective non-comparative study. Inclusion criteria comprised: adult patient, with chronic tinnitus, Tinnitus Handicap Inventory (THI) score > 17, causing psychological distress motivating active treatment after ineffective “classic” treatment (combining advice, sound therapy and first-line drug treatment), and agreement to EMDR therapy. Therapeutic efficacy was defined by a decrease in THI or Visual Analog Scale (VAS) scores. Treatment acceptability was defined by the rate of included patients who completed therapy.ResultsThirty-eight patients were included. There was a significant reduction of 53.5% in THI score in 78.9% of patients (P < 0.0001; 64.8 ± 20.8 before versus 31.8 ± 24.7 after treatment), and of 51% in VAS score in 76.3% of patients (P < 0.0001; 7.24 ± 2.12 before versus 3.58 ± 2.03 after treatment). The treatment acceptability was 86.8%.ConclusionEMDR appeared to be an effective alternative that was acceptable to the majority of patients, after failure of “classic” first-line treatment, improving quality of life in tinnitus patients and thus relieving disability. 相似文献
6.
目的探讨针刺京骨穴联合推拿治疗背肌筋膜炎的临床疗效。方法将2016年10月—2018年10月收治的背肌筋膜炎患者86例纳入研究,采用随机数字表法分组。对照组43例予以推拿治疗,观察组43例予以针刺京骨穴联合推拿治疗。比较2组患者的治疗总有效率、VAS评分及Oswestry功能障碍指数、痊愈所用时间。结果观察组治疗总有效率为95.3%,而对照组仅为81.4%,差异有统计学意义(P<0.05);2组治疗后VAS评分、Oswestry功能障碍指数均有下降,观察组上述指标低于对照组,差异有统计学意义(P<0.05);观察组痊愈所用时间短于对照组,差异有统计学意义(P<0.05)。结论针刺京骨穴联合推拿治疗背肌筋膜炎的临床疗效突出,可缓解背部疼痛、恢复功能活动,并缩短了愈合时间,提高了生活质量,值得一定的临床推广。 相似文献
7.
8.
9.
随着对于双心疾病研究的加深,西医疗法的弊端也开始显现。而中医因其理论架构中早就有对于“心主血脉”和“心主神明”的认识,因此在双心疾病的治疗上有着先天的优势。同时近些年中医疗法的结合应用也取得不错的成绩,本文通过对于双心疾病的病例分析,来研讨这种治疗手段的合理性和先进性。 相似文献
10.